MORRIS PLAINS, N.J., Sept. 8, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that it will host a R&D day on Wednesday, September 17, 2008 from 9:30 am - 11:30 am EDT at the Waldorf Astoria Hotel in New York City. Featured presenters at the event will be Dr. John Leonard, the Richard T. Silver Distinguished Professor at Weill Cornell Medical College and Dr. Kenneth Pennington, Medical Oncologist at Goshen Center for Cancer Care. In addition, Immunomedics’ senior management and scientific team will provide a detailed update on the Company’s product pipeline and technology. A live audio webcast of the presentation and accompanying slides will be available to all interested parties through the Investor Relations section of the Company’s website at www.immunomedics.com. An archived version of the webcast will be available through October 16, 2008 at the same location.
